Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.945 USD | -5.91% | +16.87% | -30.05% |
02/05 | CUREVAC : A missed opportunity | |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.05% | 701M | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : Could Allow Manufacturing Partners To Produce Rival Vaccines